Msika Wothandizira Matenda a Huntington kukula kwake kunali kwamtengo wapatali $ 325 miliyoni mu 2021, kuti $ 1813.18 miliyoni pofika 2030, kuwonetsa a CAGR ya 19.5% pakati pa 2022-2030.
Panthawi yolosera, gawo lomwe likukula mwachangu pamsika wamankhwala osintha matenda akuyembekezeka kukhala lomwe likukula kwambiri. Izi ndichifukwa chakuchulukira kwa R&D pamankhwala osintha matenda komanso kukwera kwa kufunikira kwa zinthu zapamwamba monga gene therapy kapena stem cell therapy. M'tsogolomu, msika ukhoza kulimbikitsidwa ndi zoyeserera zaboma monga Fast Track Designation (US FDA), zomwe zimafulumizitsa kulembetsa. Mankhwala a Sage Therapeutics SAGE-718 adasankhidwa mwachangu ndi US FDA mu Seputembara 2021 ngati chithandizo chotheka ku Matenda a Huntington.
Mutha Kufunsira Chiwonetsero cha Lipotilo Musanagule Apa: https://market.us/report/huntington-s-disease-treatment-market/request-sample/
Msika wa Chithandizo cha Matenda a Huntington: Madalaivala
Kuchulukitsidwa Kwachidziwitso Chachidziwitso Chachidziwitso ndi Mankhwala Othandizira Kufuna Njira Zochizira.
Kukula kwa msika kudzayendetsedwa ndi kutengapo gawo kwa omwe akuchita nawo makampani posaka chithandizo cha matenda a Huntington (HD). Izi zitha kukhala chifukwa cha kuchuluka kwa odwala komanso kuchuluka kwa matenda ku Europe ndi North America. Kukula kwa msika kudzathandizidwa ndi kufunikira kosakwanira kwa mankhwala osintha a HD ndi machiritso.
Kuchulukitsa Kafukufuku ndi Chitukuko Kuti Mufulumizitse Kukula Kwa Msika.
Matenda a Huntington ndi osachiritsika. Palibe mankhwala kapena mankhwala. Izi zikutanthauza kuti pali mwayi wambiri wofufuza ndikupanga njira zatsopano zochiritsira. Izi zitha kukulitsa kukula kwa msika kwambiri panthawi yolosera. Mapulogalamu aboma omwe angathe kulimbikitsa chitukuko cha mankhwala atsopano adzakhala chinthu china chomwe chikuyendetsa kukula kwa msika.
Msika Wothandizira Matenda a Huntington: Zoletsa
Kuperewera kwa mankhwala kumalepheretsa kukula kwa msika.
Matenda a Huntington ali ndi chiwerengero choletsedwa chamankhwala omwe ali ndi zilolezo chifukwa cha miyezo ndi zoletsa. Izi zitha kuchepetsa kukula kwa msika munthawi yonse yolosera. Chifukwa chakusalidwa kokhudzana ndi matenda a Huntington, kuzindikira kochepa m'madera ambiri a dziko lapansi, ziletso zokhwima zovomerezeka ndi mankhwala, mapulani a njira zochiritsira zosagwiritsidwa ntchito masiku onse, ndi mankhwala ochepa ovomerezeka akhoza kuchepetsa kukula kwa msika.
Zomwe Zachitika Pamsika:
Msika Wothandizira Matenda a Huntington akuyembekezeka kukhala ndi gawo lalikulu pamsika wa Symptomatic Treatment Segment.
Gawo lalikulu kwambiri likuyembekezeka kuchitidwa ndi gawo lachidziwitso chazidziwitso pazaka zanenedweratu. Ndalama zamagulu zawonjezeka chifukwa cha kupezeka kwakukulu komanso kuchuluka kwa kagwiritsidwe ntchito pamankhwala owongolera zizindikiro. Gawoli limapanga ndalama zambiri chifukwa chofuna chithandizo chamankhwala angapo komanso kulowererapo kwa gulu la akatswiri osiyanasiyana.
Kuwonongeka kwa magalimoto ndi chorea ndizofunikira kwambiri pakukula kwazizindikiro zachipatala. Chorea akadali chizindikiro chofala kwambiri cha matenda a Huntington. Maphunziro ambiri achire achitikapo. Mwachitsanzo, Neurocrine Biosciences, adalengeza kuti valentine idachepetsa kwambiri chorea mwa odwala a Huntington muyeso lachipatala la Phase 3 lotchedwa-KINECT HD mu Disembala 2021. Pepala lofufuza la Meyi 2021 lofalitsidwa mu Brain lidawonetsa kuti kusintha kwa majini kumatha kuchepetsa kufalikira kwa zizindikiro. Maphunziro omwe akupitilirawa atenga gawo lofunikira pakuwunika msika wagawoli pazaka zikubwerazi.
Zomwe zachitika posachedwa:
Ionis Pharmaceuticals, Inc. idalengeza mu Januwale 2022 mgwirizano ndi Roche kuti awunike tominersen muyeso la Gawo 2 la chithandizo cha matenda a Huntington.
Novartis, wopanga mankhwala osintha matenda a matenda a Huntington, adalengeza kuti Novartis adapatsidwa udindo wa FDA Fast Track mu Disembala 2021.
Malo Opikisana:
- Valeant Mankhwala
- Teva Pharmaceuticals
- Sayansi Yamoyo Wamafunde
- Ionis Pharmaceuticals / Roche
- Malingaliro a kampani Raptor Pharmaceuticals
- Prana Biotechnology
Type
- Symptomatic Therapy
- Chithandizo Chosintha Matenda
ntchito
- zipatala
- Malo Opangira Opaleshoni
Makampani, Mwa Dera
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- Middle East & Africa [GCC, North Africa, South Africa]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
Mafunso ofunikira:
- Kodi kukula kwa msika wazochizira matenda a Huntington kukukula pati?
- Kodi ndindani omwe akutenga nawo gawo kwambiri pamsika wochiza matenda a Huntington?
- Kodi mtengo wamsika womwe ukuyembekezeredwa ndi chiyani pakuchiritsa matenda a Huntington mu 2031?
- Ndi dera liti lomwe lapanga ndalama zambiri pamsika pochiza matenda a Huntington?
- Kodi ndindani omwe akutenga nawo gawo kwambiri pamsika wochiza matenda a Huntington?
- Ndi mitundu yanji yomwe ikukhudza msika wazochizira matenda a Huntington?
- Kodi ndi CAGR yotani yomwe msika wazochizira matenda a Huntington unakula pakati pa 2015 ndi 2021?
- Kodi kusintha kwakukulu kwa ogula ndi kotani pamene chuma chikusintha?
- Ndi zovuta zotani zomwe ma SME ndi ogulitsa odziwika bwino amakumana nawo pamsika pochiza matenda a Huntington?
Malipoti Ena Ofananirako kuchokera patsamba lathu la Market.us:
Kukula Kwamsika Wapadziko Lonse Wothandizira Matenda a Sickle-Cell zinali zofunikira USD 1.9 Biliyoni mu 2021 ndipo akuyembekezeka kukumana ndi a 17.9% CAGR mu 2023-2032.
Msika Wapadziko Lonse Wothandizira Ululu Wapadziko Lonse akuyembekezeka kukwaniritsa kuwunika kwa $ 173.53 Bn pofika 2031 pa CAGR ya 7.2%, kuchokera $ 86.58 Bn mu 2021.'
Msika Wochiza Matenda a Genital Warts akuyembekezeka kufika pa mtengo wa $2.16 Mabiliyoni pofika 2032 pa CAGR ya 4.8%, kuchokera USD 1.63 Biliyoni mu 2021.
Msika Wapadziko Lonse Wa Acne Scar Treatment akuyembekezeka kufika pa mtengo wa $ 82.59 Bn pa 2032 a CAGR of 13.85%, kuchokera $ 27.32 Bn mu 2022.
Msika wapadziko lonse wa mankhwala a acromegaly anali wofunika USD 1,497 miliyoni mu 2021. Akuyembekezeka kukula 7.55% nthawi yaneneratu.
Zambiri pa Market.us
Market.US (Powered by Prudour Private Limited) imagwira ntchito pakufufuza mozama ndi kusanthula msika ndipo yakhala ikutsimikizira kuti ili ngati kampani yofunsira komanso yosinthidwa mwamakonda amsika, kupatula kuti lipoti lofufuza zamsika lomwe limafunidwa kwambiri lomwe limapereka.
Zowonjezera:
Global Business Development Team - Market.us
Adilesi: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Foni: +1 718 618 4351 (Yapadziko Lonse), Foni: +91 78878 22626 (Asia)
Email: [imelo ndiotetezedwa]
ZOMWE MUNGACHITE PA NKHANIYI:
- Over the forecast period, the fastest growing segment in the disease-modifying therapies market is expected to be the one with the highest growth.
- announced in January 2022 a partnership with Roche to evaluate tominersen in a Phase 2 trial for Huntington’s Disease treatment.
- Due to the stigma associated with Huntington's disease, low awareness in many parts of the world, strict drug approval restrictions, alternative therapies plans, and a small number of approved drugs will likely limit the market growth.
